{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:56:15Z","timestamp":1789419375646,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04481-y","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:36:14Z","timestamp":1764146174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term prognostic value of postoperative C-reactive protein in gastric cancer patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Dong Yang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Bo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"7","key":"4481_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/0115734129322567240821052326","volume":"20","author":"CV Chandarana","year":"2024","unstructured":"Chandarana CV, Mithani NT, Singh DV, et al. Vibrational spectrophotometry: a comprehensive review on the diagnosis of gastric and liver cancer. Curr Pharm Anal. 2024;20(7):453\u201365. https:\/\/doi.org\/10.2174\/0115734129322567240821052326.","journal-title":"Curr Pharm Anal"},{"issue":"5","key":"4481_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.32604\/biocell.2023.028587","volume":"47","author":"Y WANG","year":"2023","unstructured":"WANG Y, CHEN S, YU P, et al. SR-BI expression regulates the gastric cancer tumor immune microenvironment and is associated with poor prognosis. BIOCELL. 2023;47(5):991\u20131002. https:\/\/doi.org\/10.32604\/biocell.2023.028587.","journal-title":"BIOCELL"},{"key":"4481_CR3","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429318398240918063450","volume":"17","author":"X Zhang","year":"2024","unstructured":"Zhang X, Jin M, Yao X, et al. Upregulation of LncRNA WT1-AS inhibits tumor growth and promotes autophagy in gastric cancer via suppression of PI3K\/Akt\/mTOR pathway. Curr Mol Pharmacol. 2024;17:e18761429318398. https:\/\/doi.org\/10.2174\/0118761429318398240918063450.","journal-title":"Curr Mol Pharmacol"},{"issue":"7","key":"4481_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.2174\/1874467216666230103104600","volume":"16","author":"J Song","year":"2023","unstructured":"Song J, Xu X, He S, et al. Myristicin suppresses gastric cancer growth via targeting the EGFR\/ ERK signaling pathway. Curr Mol Pharmacol. 2023;16(7):712\u201324. https:\/\/doi.org\/10.2174\/1874467216666230103104600.","journal-title":"Curr Mol Pharmacol"},{"issue":"5","key":"4481_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.32604\/biocell.2023.028402","volume":"47","author":"M REN","year":"2023","unstructured":"REN M, YANG Y, LI D, et al. Network pharmacology and molecular docking identify mechanisms of medicinal plant-derived 1,2,3,4,6-penta-O-galloyl-beta-D-glucose treating gastric cancer. BIOCELL. 2023;47(5):977\u201389. https:\/\/doi.org\/10.32604\/biocell.2023.028402.","journal-title":"BIOCELL"},{"issue":"3","key":"4481_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","volume":"86","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86(3):566\u201382. https:\/\/doi.org\/10.1016\/j.semcancer.2021.12.004.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"4481_CR7","doi-asserted-by":"publisher","first-page":"e36597","DOI":"10.7759\/cureus.36597","volume":"15","author":"H Yazici","year":"2023","unstructured":"Yazici H, Yegen SC. Is systemic inflammatory response index (SIRI) a reliable tool for prognosis of gastric cancer patients without neoadjuvant therapy? Cureus. 2023;15(3):e36597. https:\/\/doi.org\/10.7759\/cureus.36597.","journal-title":"Cureus"},{"issue":"3","key":"4481_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.7150\/jca.52299","volume":"12","author":"Y Ma","year":"2021","unstructured":"Ma Y, Lin J, Lin J, et al. A novel prognosis marker based on combined preoperative carcinoembryonic antigen and systemic inflammatory response for resectable gastric cancer. J Cancer. 2021;12(3):927\u201335. https:\/\/doi.org\/10.7150\/jca.52299.","journal-title":"J Cancer"},{"issue":"12","key":"4481_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/genes9120631","volume":"9","author":"TK Furuya","year":"2018","unstructured":"Furuya TK, Jacob CE, Tomit\u00e3o MTP, et al. Association between polymorphisms in inflammatory response-related genes and the susceptibility, progression and prognosis of the diffuse histological subtype of gastric cancer. Genes. 2018;9(12):631. https:\/\/doi.org\/10.3390\/genes9120631.","journal-title":"Genes"},{"issue":"22","key":"4481_CR10","doi-asserted-by":"publisher","first-page":"e38376","DOI":"10.1097\/MD.0000000000038376","volume":"103","author":"C Liu","year":"2024","unstructured":"Liu C, Lu J, An L. Development and validation of nomograms for predicting the prognosis of early and late recurrence of advanced gastric cancer after radical surgery based on post-recurrence survival. Med. 2024;103(22):e38376. https:\/\/doi.org\/10.1097\/MD.0000000000038376.","journal-title":"Med"},{"issue":"42","key":"4481_CR11","doi-asserted-by":"publisher","first-page":"e35585","DOI":"10.1097\/MD.0000000000035585","volume":"102","author":"C Liu","year":"2023","unstructured":"Liu C, Tao F, Lu J, et al. Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy. Med. 2023;102(42):e35585. https:\/\/doi.org\/10.1097\/MD.0000000000035585.","journal-title":"Med"},{"issue":"15","key":"4481_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158100","volume":"23","author":"T Levinson","year":"2022","unstructured":"Levinson T, Wasserman A. C-reactive protein velocity as a new biomarker for the early detection of acute infection\/inflammation. Int J Mol Sci. 2022;23(15):8100. https:\/\/doi.org\/10.3390\/ijms23158100.","journal-title":"Int J Mol Sci"},{"key":"4481_CR13","doi-asserted-by":"publisher","first-page":"720876","DOI":"10.3389\/fimmu.2021.720876","volume":"12","author":"S Si","year":"2021","unstructured":"Si S, Li J, Tewara MA, Xue F. Genetically determined chronic low-grade inflammation and hundreds of health outcomes in the UK biobank and the FinnGen population: a phenome-wide Mendelian randomization study. Front Immunol. 2021;12:720876. https:\/\/doi.org\/10.3389\/fimmu.2021.720876.","journal-title":"Front Immunol"},{"issue":"1","key":"4481_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12885-021-09113-8","volume":"22","author":"K Kasahara","year":"2022","unstructured":"Kasahara K, Enomoto M, Udo R, et al. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study. BMC Cancer. 2022;22(1):20. https:\/\/doi.org\/10.1186\/s12885-021-09113-8.","journal-title":"BMC Cancer"},{"issue":"3","key":"4481_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030616","volume":"16","author":"Y Takemoto","year":"2024","unstructured":"Takemoto Y, Tanabe K, Chikuie E, et al. Preoperative high C-reactive protein to albumin ratio predicts short- and long-term postoperative outcomes in elderly gastric cancer patients. Cancers (Basel). 2024;16(3):616. https:\/\/doi.org\/10.3390\/cancers16030616.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4481_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/den.14172","volume":"34","author":"Y Ogata","year":"2022","unstructured":"Ogata Y, Hatta W, Ohara Y, et al. Predictors of early and late mortality after the treatment for early gastric cancers. Dig Endosc. 2022;34(4):816\u201325. https:\/\/doi.org\/10.1111\/den.14172.","journal-title":"Dig Endosc"},{"key":"4481_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/CLEP.S415171","volume":"15","author":"T Gwenzi","year":"2023","unstructured":"Gwenzi T, Zhu A, Schrotz-King P, et al. Prognostic value of post-operative C-reactive protein-based inflammatory biomarkers in colorectal cancer patients: systematic review and meta-analysis. Clin Epidemiol. 2023;15:795\u2013809. https:\/\/doi.org\/10.2147\/CLEP.S415171.","journal-title":"Clin Epidemiol"},{"issue":"10","key":"4481_CR18","doi-asserted-by":"publisher","first-page":"ED000129","DOI":"10.1002\/14651858.ED000129","volume":"10","author":"KG Moons","year":"2018","unstructured":"Moons KG, Hooft L, Williams K, et al. Implementing systematic reviews of prognosis studies in Cochrane. Cochrane Database Syst Rev. 2018;10(10):ED000129. https:\/\/doi.org\/10.1002\/14651858.ED000129.","journal-title":"Cochrane Database Syst Rev"},{"issue":"364","key":"4481_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/bmj.k4597","volume":"2019","author":"RD Riley","year":"2019","unstructured":"Riley RD, Moons KGM, Snell KIE, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ. 2019Jan;2019(364):30. https:\/\/doi.org\/10.1136\/bmj.k4597.","journal-title":"BMJ."},{"issue":"34","key":"4481_CR20","doi-asserted-by":"publisher","first-page":"55765","DOI":"10.18632\/oncotarget.9910","volume":"7","author":"F Kong","year":"2016","unstructured":"Kong F, Gao F, Chen J, et al. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer. Oncotarget. 2016;7(34):55765\u201370. https:\/\/doi.org\/10.18632\/oncotarget.9910.","journal-title":"Oncotarget"},{"issue":"1","key":"4481_CR21","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1038\/s41598-022-07098-3","volume":"12","author":"K Kuroda","year":"2022","unstructured":"Kuroda K, Toyokawa T, Miki Y, et al. Prognostic impact of postoperative systemic inflammatory response in patients with stage II\/III gastric cancer. Sci Rep. 2022;12(1):3025. https:\/\/doi.org\/10.1038\/s41598-022-07098-3.","journal-title":"Sci Rep"},{"issue":"5","key":"4481_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10120-020-01073-5","volume":"23","author":"Y Kurokawa","year":"2020","unstructured":"Kurokawa Y, Yamashita K, Kawabata R, et al. Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study. Gastric Cancer. 2020;23(5):937\u201343. https:\/\/doi.org\/10.1007\/s10120-020-01073-5.","journal-title":"Gastric Cancer"},{"issue":"1","key":"4481_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s40001-023-01334-w","volume":"28","author":"C Li","year":"2023","unstructured":"Li C, Yang X, Li H, et al. Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer. Eur J Med Res. 2023;28(1):360. https:\/\/doi.org\/10.1186\/s40001-023-01334-w. Published 2023 Sep 21.","journal-title":"Eur J Med Res"},{"issue":"1","key":"4481_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/cam4.3514","volume":"10","author":"J Lu","year":"2021","unstructured":"Lu J, Xu BB, Xue Z, et al. Perioperative CRP: A novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit. Cancer Med. 2021;10(1):34\u201344. https:\/\/doi.org\/10.1002\/cam4.3514.","journal-title":"Cancer Med"},{"key":"4481_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ags3.70006","volume":"00","author":"R Matsui","year":"2025","unstructured":"Matsui R, Ohashi M, Ri M, Makuuchi R, Irino T, Hayami M, et al. Prognostic impact of postoperative fixed-point inflammation in patients with gastric cancer after curative gastrectomy: A validation cohort study. Ann Gastroenterol Surg. 2025;00:1\u201313. https:\/\/doi.org\/10.1002\/ags3.70006.","journal-title":"Ann Gastroenterol Surg"},{"key":"4481_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jss.2019.04.075","volume":"242","author":"K Migita","year":"2019","unstructured":"Migita K, Matsumoto S, Wakatsuki K, et al. Postoperative serum C-reactive protein level predicts long-term outcomes in stage I gastric cancer. J Surg Res. 2019;242:323\u201331. https:\/\/doi.org\/10.1016\/j.jss.2019.04.075.","journal-title":"J Surg Res"},{"issue":"1","key":"4481_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.asjsur.2022.05.087","volume":"46","author":"T Nagata","year":"2023","unstructured":"Nagata T, Adachi Y, Taniguchi A, et al. Prognostic impacts of categorized postoperative complications in surgery for gastric cancer. Asian J Surg. 2023;46(1):451\u20137. https:\/\/doi.org\/10.1016\/j.asjsur.2022.05.087.","journal-title":"Asian J Surg"},{"issue":"8","key":"4481_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/jso.24067","volume":"112","author":"T Saito","year":"2015","unstructured":"Saito T, Kurokawa Y, Miyazaki Y, et al. Which is a more reliable indicator of survival after gastric cancer surgery: postoperative complication occurrence or C-reactive protein elevation? J Surg Oncol. 2015;112(8):894\u20139. https:\/\/doi.org\/10.1002\/jso.24067.","journal-title":"J Surg Oncol"},{"issue":"8","key":"4481_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00262-019-02366-0","volume":"68","author":"S Urakawa","year":"2019","unstructured":"Urakawa S, Yamasaki M, Goto K, et al. Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells. Cancer Immunol Immunother. 2019;68(8):1341\u201350. https:\/\/doi.org\/10.1007\/s00262-019-02366-0.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"4481_CR30","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.3892\/ol.2018.7826","volume":"15","author":"SQ Yuan","year":"2018","unstructured":"Yuan SQ, Nie RC, Chen YM, et al. Glasgow prognostic score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding. Oncol Lett. 2018;15(4):4193\u2013200. https:\/\/doi.org\/10.3892\/ol.2018.7826.","journal-title":"Oncol Lett"},{"issue":"6","key":"4481_CR31","first-page":"846","volume":"23","author":"J Zang","year":"2021","unstructured":"Zang J, Gao M, Wang L, et al. Correlation analysis of serum C-reactive protein level with clinical features and prognosis in patients with laparoscopic radical gastrectomy for gastric cancer. Zhejiang Clin Med J. 2021;23(6):846\u20138.","journal-title":"Zhejiang Clin Med J"},{"key":"4481_CR32","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429322420241112051105","volume":"17","author":"S Fatima","year":"2024","unstructured":"Fatima S, Song Y, Zhang Z, et al. Exploring the pharmacological mechanisms of P-hydroxylcinnamaldehyde for treating gastric cancer: a pharmacological perspective with experimental confirmation. Curr Mol Pharmacol. 2024;17:e18761429322420. https:\/\/doi.org\/10.2174\/0118761429322420241112051105.","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"4481_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.32604\/biocell.2023.043474","volume":"48","author":"J CAO","year":"2024","unstructured":"CAO J, LI S, ZHANG T, et al. Valtrate exerts anticancer effects on gastric cancer AGS cells by regulating reactive oxygen species-mediated signaling pathways. BIOCELL. 2024;48(2):313\u201325. https:\/\/doi.org\/10.32604\/biocell.2023.043474.","journal-title":"BIOCELL"},{"issue":"11","key":"4481_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012. https:\/\/doi.org\/10.3390\/ijms21114012.","journal-title":"Int J Mol Sci"},{"issue":"7203","key":"4481_CR35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature"},{"key":"4481_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathmechdis-032221-115501","volume":"17","author":"L Maiorino","year":"2022","unstructured":"Maiorino L, Da\u00dfler-Plenker J, Sun L, et al. Innate immunity and cancer pathophysiology. Annu Rev Pathol. 2022;17:425\u201357. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-032221-115501.","journal-title":"Annu Rev Pathol"},{"key":"4481_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"4481_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4174\/astr.2021.100.6.338","volume":"100","author":"Q Yu","year":"2021","unstructured":"Yu Q, Li KZ, Fu YJ, et al. Clinical significance and prognostic value of C-reactive protein\/albumin ratio in gastric cancer. Ann Surg Treat Res. 2021;100(6):338\u201346. https:\/\/doi.org\/10.4174\/astr.2021.100.6.338.","journal-title":"Ann Surg Treat Res"},{"issue":"2","key":"4481_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12029-021-00584-3","volume":"53","author":"Y Shimoda","year":"2022","unstructured":"Shimoda Y, Fujikawa H, Komori K, et al. Preoperative utility of the Glasgow prognostic score on outcomes of patients with locally advanced gastric cancer. J Gastrointest Cancer. 2022;53(2):265\u201371. https:\/\/doi.org\/10.1007\/s12029-021-00584-3.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"4481_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12916-022-02506-x","volume":"20","author":"M Zhu","year":"2022","unstructured":"Zhu M, Ma Z, Zhang X, et al. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis. BMC Med. 2022;20(1):301. https:\/\/doi.org\/10.1186\/s12916-022-02506-x.","journal-title":"BMC Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04481-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T01:52:38Z","timestamp":1767059558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04481-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04481-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"887"}}